Dr. Salem Chouaib completed his undergraduate studies in biochemistry at the University of Pierre and Marie Curie (Paris VI) and immunology at Pasteur Institute. In 1983, he received his Doctorate in immunology (lab of Jean Dausset) from the same university. He then joined the Memorial Sloan Kettering Cancer Center in New York where he undertook post-doctoral training in the Human Immunogenetics Lab. In 1986 he was appointed as a research associate at INSERM and joined the tumor biology laboratory at the Institute Gustave Roussy. At present he is heading a research unit devoted to cancer immunology and immunotherapy. Dr Chouaib’s lab focuses on investigating the functional cross talk between cytotoxic cells and tumor targets in the context of tumor microenvironment complexity and plasticity. His research was constantly directed at the transfer of fundamental concepts to clinical application, especially in the field of cancer vaccine and cancer immunotherapy. He was awarded the cancer research prize of the French ligue against cancer (1992) and the presidential prize in biotechnology (2004). He is lecturing tumor immunology for the PhD programs at the University Paris Sud and is a guest lecturer at different universities. He has published >220 scientific articles and several reviews in the field of human immunology and tumor biology. He is a member of various professional associations and a scientific advisor and consultant in many scientific institutions.